Ashwin is a Partner/Principal within EY’s Strategy and Transactions team. He is focused on corporate and commercial strategy for biopharma across growth strategy, transaction support and operating model transformation. Ashwin has spent his career across large pharmaceutical organizations, specialty pharmaceutical and pre-revenue biotechs.